coptisine has been researched along with Anasarca in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HB; Li, CL; Liang, JL; Lin, GS; Luo, CD; Su, ZR; Tan, LH; Wu, JZ; Xie, JH; Yang, XB; Zeng, HF; Zhang, ZB | 1 |
| Hu, Y; Huang, W; Jiang, Q; Li, S; Liu, D; Lu, X; Luo, Y; Meng, X; Wang, F; Wang, P; Wu, J; Xiang, L; Zhang, G | 1 |
| Hu, B; Meng, X; Wang, F; Wang, P; Wu, J; Yang, L; Zhang, H | 1 |
3 other study(ies) available for coptisine and Anasarca
| Article | Year |
|---|---|
Anti-inflammatory activity of coptisine free base in mice through inhibition of NF-κB and MAPK signaling pathways.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Berberine; Capillary Permeability; Dinoprostone; Dose-Response Relationship, Drug; Edema; Female; Gene Expression Regulation; Interleukin-1beta; Interleukin-6; Male; MAP Kinase Signaling System; Mice; NF-kappa B; Tumor Necrosis Factor-alpha | 2017 |
Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Caspase 1; Caspase Inhibitors; Coptis; Edema; Gout; Interleukin-1beta; Lipopolysaccharides; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; RAW 264.7 Cells | 2019 |
Coptisine from Coptis chinensis inhibits production of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 murine macrophage cells.
Topics: Animals; Berberine; Coptis; Edema; Enzyme Activation; Gene Expression Regulation; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Synthase Type II; Proto-Oncogene Proteins c-akt; Rats; RAW 264.7 Cells; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4 | 2016 |